Nivolumab-induced cholangitis in patients with non-small cell lung cancer: Case series and a review of literature.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hiroki,Izumi

第一单位： Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683-8504, Japan.

作者： Hiroki,Izumi ^[1] ; Masahiro,Kodani ^[1] ; Jun,Kurai ^[1] ; Kenichi,Takeda ^[1] ; Ryota,Okazaki ^[1] ; Kohei,Yamane ^[1] ; Yasuhiko,Teruya ^[1] ; Akihiro,Yamamoto ^[1] ; Yuriko,Sueda ^[1] ; Masaaki,Yanai ^[1] ; Natsumi,Tanaka ^[1] ; Tomohiro,Sakamoto ^[1] ; Kosuke,Yamaguchi ^[1] ; Haruhiko,Makino ^[1] ; Tadashi,Igishi ^[1] ; Akira,Yamasaki ^[1]

作者单位： Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683-8504, Japan. ^[1]

关键词 cholangitis immune-related adverse event mycophenolate mofetil nivolumab non-small cell lung cancer

DOI 10.3892/mco.2019.1923

PMID 31616560

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular and clinical oncology

2019年11卷5期

439-446页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Nivolumab-induced cholangitis in patients with non-small cell lung cancer: Case series and a review of literature.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Nivolumab-induced cholangitis in patients with non-small cell lung cancer: Case series and a review of literature.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

检索历史清除